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Abstract. Stable attachment of external epithelia to the 
basement membrane and underlying stroma is medi- 
ated by transmembrane proteins such as the integrin 
et6134 and buUous pemphigoid antigen 2 within the 
hemidesmosomes along the basolateral surface of the 
epithelial cell and their ligands that include a special- 
ized subfamily of laminins. The laminin 5 molecule 
(previously termed kalinin/nicein/epiligrin) is a mem- 
ber of this epithelial-specific subfamily. Laminin 5 
chains are not only considerably truncated within do- 
mains III-VI, but are also extensively proteolytically 
processed in vitro and in vivo. As a result, the domains 
expected to be required for the association of laminins 
with other basement membrane components are lack- 
ing in the mature laminin 5 molecule. Therefore, the 
tight binding of laminin 5 to the basement membrane 
may occur by a unique mechanism. To examine laminin 
5 in tissue, we chose human amnion as the source, be- 
cause of its availability and the similarity of the amni- 
otic epithelial basement membrane with that of skin. 
We isolated the laminin 5 contained within the base- 
ment membrane of human amnion. In addition to 
monomeric laminin 5, we find that much of the laminin 
5 isolated is covalently adducted with laminin 6 
(o~31M~/1) and a novel laminin isotype we have termed 
laminin 7 (or3 1~2 ~/1). We propose that the association 
between laminin 5 and laminins 6 and 7 is a mechanism 
used in amnion to allow stable association of laminin 5 
with the basement membrane. The 1~2 chain is seen at 
the human amniotic epithelial-stromal interface and at 
the dermal-epidermal junction of fetal and adult bo- 
vine skin by immunofluorescence, but is not present, or 
only weakly present, in neonatal human skin. 
T 
hE attachment of external epithelia to the underly- 
ing stroma is mediated by a unique set of ultrastruc- 
tural entities within the basement membrane zone 
called the attachment complex (Gipson et al., 1987). This 
complex includes hemidesmosomes on the basolateral sur- 
face of the epithelium (Kelly, 1966),  anchoring filaments 
that bridge the hemidesmosomes with the lamina densa 
(Komura,  1973),  and  anchoring fibrils that form an ex- 
tended network surrounding stromal fibrous elements and 
insert into the basement membrane (Bruns, 1969).  Char- 
acterization of the components of the complex show that 
the  hemidesmosomes  contain  an  intracellular  protein, 
bullous pemphigoid antigen (BPAG)X-1, with homology to 
desmoplakin that is assumed to mediate the interaction of 
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the hemidesmosomes with the cytokeratin network (Labib 
et al., 1986; Tanaka et al., 1991), HD-1 (Hieda et al., 1992), 
and BPAG-2, a transmembrane protein whose exodomain 
contains amino acid sequences that predict potential tri- 
ple-helical structure (Li et al., 1991). Therefore, BPAG-2 
has also been called type XVII collagen. The hemidesmo- 
some also contains the integrin a6134 (Carter et al., 1990; 
Stepp et al., 1990). The anchoring fibrils are condensations 
of type VII collagen dimers (Sakai et al., 1986; Morris et 
al., 1986; Keene et al., 1987). The anchoring filaments con- 
tain laminin 5 (previously called kalinin [Rousselle et al., 
1991]/nicein  [Verrando, et al., 1987], and likely to be con- 
tained in the preparation termed epiligrin [Carter et al., 
1991; see  Burgeson et  al.,  1994  for nomenclature]), the 
exodomain of type XVII collagen and perhaps other pro- 
teins (Fine et al., 1989; Chan et al., 1993). 
Laminin 5 is a unique laminin variant composed of three 
nonidentical subunits (Rousselle et al., 1991), a3 (Ryan et 
al., 1994), [33 (Gerecke et al., 1994; Utani et al., 1995), and 
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al., 1995), each of which is substantially truncated within 
the short arm domains relative to laminin 1. In addition, 
laminin  5  is  proteolytically  processed  after  secretion 
(Marinkovich et al., 1992b). In addition to domains I and 
II, the proteolytic product retains only the G  domain at 
the COOH terminus of the et3 chain, a globular domain at 
the end of the 133 chain that is homologous to the VI do- 
main of 131, and portions of the EGF-like domains. The 
molecule lacks the ability to bind nidogen/entactin (Mayer 
et al., 1995). 
Laminin 5 is essential for epidermal--dermal adhesion. 
Gene defects in the 133 (Pulkkinen et al.,  1994a) and ~/2 
chains  (Pulkkinen  et  al.,  1994b;  Aberdam  et  al.,  1994; 
Vailly et al.,  1994) underlie the Herlitz's variety of junc- 
tional epidermolysis buUosa, a  lethal disease causing ex- 
tensive dermal-epidermal separation in the plane of the 
lamina lucida. Therefore, laminin 5 must interact with the 
epithelial cell surface and with components of the base- 
ment membrane. There are now abundant data from both 
in vitro and in vivo studies that indicate that cells bind to 
laminin 5 via a6134 (Sonnenberg et al., 1993; Niessen et al., 
1994) and tx3131 (Carter et al., 1990, 1991). However, how 
an association with the basement membrane occurs in the 
absence of the short arm domains thought to be involved 
in the assembly of laminins 1, 2, 3, and 4 with the lamina 
densa is unclear. Here we report studies of the molecules 
associated with laminin 5 in human amniotic membrane 
and observe a novel laminin variant containing or3, 132 (S- 
chain)  (Hunter et al.,  1989a), and ~/1. The description of 
this molecule and its association with laminin 5 is the focus 
of this report. We suggest the name laminin 7 for the trimeric 
assembly of ct3, [32, ~/1. Laminin 5 is also found covalently 
associated with laminin 6 in amnion. 
[32 has been described by Hunter et al. (1989a) as having 
overall structural similarity to 131. 132 is contained in lami- 
nin 3 (S-laminin) together with etl and T1, and in laminin 4 
(S-merosin) combined with or2 and ",/1 (Green et al., 1992). 
Unlike laminin 1 that is present in most basement mem- 
branes, the distribution of the 132 is considerably restricted 
to the motor neuron synapse, blood vessels, and the kid- 
ney glomerulus (Hunter et al., 1989a; Engvall et al., 1990; 
Engvall,  1993).  To date,  no  functional differences have 
been reported between laminins 1, 2, 3, and 4 relative to 
the epithelial basement membrane. 
The basement membrane zone underlying the amniotic 
epithelium is ultrastructurally and biochemically similar to 
the  structures  underlying  other  external  epithelia.  As 
shown in Fig. 1, typical anchoring complex structures are 
visualized that include hemidesmosomes, anchoring fila- 
ments,  and  anchoring  fibrils.  The  components  of these 
complexes and the association of these components have 
previously been considered typical of external epithelial 
basement membranes as well, as exemplified by proposed 
requirement of dimerization of type VII collagen before 
anchoring fibril formation (Keene et al., 1987; Lunstrum et 
al., 1987), which was based upon interactions of type VII 
collagen molecules extracted from  amnion.  This model, 
now eight years old, has continued to be consistent with 
data accumulated from biochemical studies and with mod- 
els  of pathogenesis  resulting  from  COL7A1  mutations. 
The processing of laminin 5 observed in keratinocyte cul- 
ture and skin organ culture also occurs in amnion (Marin- 
kovich et al., 1992a). Therefore, we have used amnion as a 
source on epithelial laminin in this study. 
Materials and Methods 
Antibodies 
Preparations of the mAb BM 165, mAb K140 (Roussclle et al., 1991), and 
mAb 545 specific of the 131 chain of human laminin (Marinkovich et al., 
1992a) have been described, mAbs C1 and C4 were the generous gift of 
Dr. Joshua Sanes (Washington University School of Medicine, St Louis, 
MO). mAb 1924 specific of the ~1 chain of laminin was purchased from 
Chemicon Intl., Inc. (Temecula, CA). Anti-~3 peptide antibody was pre- 
pared in New Zealand White rabbits by standard procedures to a peptide 
with the amino acid sequence KANDITDEVLDGLNPIQTD  present in 
the domain I of ~3. Anfi--/2 polyclonal antibodies were prepared by affin- 
ity purification of polyclonal anti-laminin 5 on nitrocellulose containing 
the bound product of a bacterial lawn expressing a ~gtl 1 eDNA clone en- 
coding sequences from the -/2 I/II domain. The bound and eluted antibod- 
ies showed no cross-reactivity with 131,132,133, ctl, or a3 by Western analy- 
sis, although minor cross-reactivity with -/1 was detected at high antibody 
concentration. 
Protein Purification 
The purification of the laminin 5-1aminin 7 complex was carried out as fol- 
lows: human amnions were frozen in liquid nitrogen, ground in a blender 
(Waring Products Div., New Hartford, CT), and washed in 1 M NaCI. The 
final tissue pellet (200 g, wet wt) was suspended in 1 liter of extraction 
buffer (50 mM Tris-HC1, pH 7.8, 5 mM CaCI2, 625 mg/1 of N-ethylmale- 
imide, 150 mg/1 of PMSF, and 4,000 U  of bacterial collagenase (CLSPA; 
Worthington Biochemical Corp., Freehold, NJ). The suspension was incu- 
bated  at room temperature with stirring, and after 24 h,  an additional 
4,000 U of enzyme was added. The extraction was continued for another 
24 h. Unless otherwise noted, all subsequent steps were performed at 4°C. 
The soluble fraction was collected after centrifugation (30,000 g, 60 min) 
and precipitated by 300 g/liter of ammonium sulfate). The precipitated 
proteins were collected by centrifugation (30,000 g, 60 min) and redis- 
solved into chromatography buffer (2 M urea, 25 mM NaC1, 5 mM EDTA, 
and 50 mM Tris-HC1, pH 7.8). The sample was then treated with diisopro- 
pyl fluorophosphate (5 mg/liter) and dialyzed against the same buffer. Af- 
ter dialysis, 0.5 vol of buffer-equilibrated DEAE-cellulose (DE-52; What- 
man Inc., Clifton, N J) was added, and the mixture was shaken overnight. 
Material not bound to DEAE-cellulose was collected by filtration on a 
Buchner funnel (filter 4, Whatman Inc.) and precipitated by addition of 
300 g/liter of ammonium sulfate. The proteins were collected by centrifu- 
gation (30,000 g, 60 min), redissolved in the ConA buffer (0.5 M NaC1, 
5 mM CaC12, 5 mM MgCI2, and Tris-HCl 50 mM, pH 7.8), and dialyzed 
against the same buffer overnight. The fraction was applied to a 2.5 x  5 
cm  ConA-Sepharose column (Pharmacia Fine  Chemicals, Piscataway, 
NJ), and unbound material was removed by extensive washing. Bound 
proteins were  first  eluted with  10 mM et-D-Mannopyrannoside (Sigma 
Chemical Co., St. Louis, MO) and secondly with 1 M tX-D-Glucopyranno- 
side (Sigma Chemical Co.). A third elution with 1M et-D-Manno-pyranno- 
side allowed the recovery of the proteins of interest. This fraction was 
concentrated  to  10  ml on  a  concentrator  (30  kD  membrane; Amicon 
Corp., Danvers, MA) and applied to a 2.5 x  100 cm Sephacryl S-500 col- 
umn in a 0.5 M NaCI, 50 mM Tris-HC1, pH 7.8, buffer. The fractions of in- 
terest were pooled, dialyzed against Mono-Q buffer (0.1 M NaCI, 25 mM 
Tris-HC1, pH 7.8), and applied to the 1 × 5 cm Mono-Q column (Pharma- 
cia Fine Chemicals). Elution was achieved with a 60-ml, 0.1--0.5-M  NaCI 
gradient. The laminin 5--6 complex was purified from the materials not 
bound to DEAE (as described above) by clearing the preparation of fi- 
bronecfin using gelatin-Sepharose and immunoaffinity chromatography 
using an mAb 545 Sepharose column (anti-131). 
Protein Sequencing 
Protein sequencing was done according to Aebersold et al. (1987). The 
laminin 5-1aminin 7 complex was run on a polyacrylamide gel in the pres- 
ence of 2-mercaptoethanol and blotted onto a  nitrocellulose membrane 
(Bio-Rad Laboratories, Richmond, CA). The 190-kD band (132) and the 
165-kD band (tx3) were separately excised and digested by the protease 
The Journal of Cell Biology, Volume 132, 1996  1190 Figure 1.  Transmission electron micrographs of the amniotic epithelial-stromal junction  show extreme fenestration of the epithelial  ba- 
solateral surface. Typical anchoring complex structures are readily seen including hemidesmosomes (Hd), anchoring filaments (af), and 
anchoring  fibrils (AF).  Anchoring fibrils are prominent and show insertion  of the ends of the fibrils into the lamina densa (LD) at 
hemidesmosomes. In addition,  anchoring fibrils are seen within the clefts of the fenestrae, where they appear to stabilize the convolu- 
tions of the epithelial  surface. 
Lys-C. The digest product was separated by HPLC, and one fragment was 
sequenced on a sequenator (Applied Biosystems, Foster City, CA). 
Other Methods 
The following procedures were performed as previously described: SDS- 
PAGE (Laemmli, 1970), electrophoretic transfer of proteins to nitrocellu- 
lose with immunoblot analysis (Lunstrum et al., 1986), indirect immuno- 
fluorescent microscopy of frozen sections of human tissue and bovine skin 
(Sakai et al., 1986), and visualization of rotary-shadowed images by EM 
(Morris et al., 1986). 
Results 
Laminin  5-containing  complexes  from  human  amnion 
were  partially  fractionated  by  FPLC  Mono-Q  ion  ex- 
change chromatography. The materials eluted as two over- 
lapping peaks at ~0.075  and 0.125  M  NaC1 (Fig. 2).  Gel 
electrophoretic  analysis  of alternate  fractions across the 
peaks (Fig. 2) indicated two distinct patterns. The materi- 
als contained in Mono-Q peak 1 were evaluated by SDS- 
PAGE before disulfide bond reduction (Fig. 3). Three ma- 
jor bands were observed. The slowest band (B) migrated 
only a  short  distance  into the running  gel, and while its 
mass could not be accurately estimated, it is greater than 
observed for monomeric laminin.  The  second  band  (A) 
migrated to a position expected for a  laminin 5 monomer 
(~600-700  kD).  The  third  band  was very near  the  dye 
front and was not further characterized. The chain compo- 
sitions of bands A  and B  were determined  after electro- 
phoretic resolution  and  Coomassie blue  staining  of the 
reduction  product  of the  excised  gel  band  (Fig.  3),  fol- 
lowed by immunoblotting (Fig. 4, A  and B). Before reduc- 
tion band B was immunoreactive with mAb C4 (anti-132), 
polyclonal anti-laminin 1, BM-165  (anti-a3), and BM-140 
(anti-133);  band A  was also immunoreactive with anti-132, 
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exchange FPLC on Mono-Q. (Lower panel) the A2s0 profile for 
Mono-Q elution showing the separation into two peaks. (Upper 
panel) alternate fractions were analysed by SDS-PAGE on a 5% 
gel under reducing conditions. Proteins were visualized by Coo- 
massie blue staining. M r markers are shown at left. 
Figure 4.  Immunoblot characterization  of the reduced  form of 
the bands A and B (Fig. 3). After transfer to nitrocellulose, band 
A  or B proteins were visualized using:  lanes 2 and 7, Coomassie 
blue;  lanes  3  and  8,  polyclonal anti-laminin  1  (pLml)  (Sigma 
Chemical Co.) that identifies the ~/1 chain; lanes 4 and 9, mAb C4 
that identifies the 62 (a gift of Dr Sanes); lanes 5 and 10, mAb 
BM-165 that is specific for et3; lanes 6 and 11, mAb BM-140 that 
is  specific  for  133; and  lane  12,  polyclonal  anti-'y2  serum. 
Prestained molecular weight markers are in lane 1.  The results 
show that band A contains a disulfide-bonded complex of tx3, 132, 
and 71, while band B contains a3, 132, 133, ~1, and -¢2, suggesting a 
complex of two molecules of [et3, 132, -yl]s-s[a3, 1~3, ?t2]. 
anti-laminin  1,  and  anti-a3, but  not with  anti-133  (data  not 
shown).  After  reduction  of band  A,  major  bands  at 210, 
190,  165,  and  140 kD were  observed (Fig.  4, lane 2). The 
210-kD band in the position of "yl was reactive with anti- 
laminin 1 (Fig. 4, lane 3), and the 190-kD band was recog- 
nized by anti-132 (Fig. 4, lane 4). The identity of the 190-kD 
chain as human 132 was confirmed by amino acid sequenc- 
ing of a  fragment derived from the gel band.  The peptide 
sequence  was identical  to human  132 (Wewer et al.,  1994) 
over 24 amino acids (Table I). In no case was a band in the 
position of etl or 131 recognized by anti-laminin  1 antibod- 
Figure 3.  Evaluation  of  the  disulfide-bonded  complexes  con- 
tained within the first Mono-Q peak (Fig.  2). Fraction 12 of the 
first peak was analyzed by SDS-PAGE on a 3-5% gel under non- 
disulfide bond reducing conditions. The upper band (B) and the 
lower band (A) were cut from the gel, reequilibrated in sample 
buffer in presence of 10%  2-mercaptoethanol,  and run in a 5% 
SDS-PAGE gel. Proteins were visualized by Coomassie blue. Mr 
markers are shown at left of each analysis. 
ies in either peak. The remaining unidentified bands at 165 
and  145 kD in peak A  were identified  as the or3 chain by 
immunoblotting  (Fig.  4, lane 5), but neither  the 133 chain 
(Fig. 4, lane 6) nor the ~/2 chain was detected by immuno- 
blot analysis with polyclonal anti-laminin  5  or ~/2-specific 
antibody (data not shown), or by Coomassie blue staining 
(Fig. 4, lane 2). The identity of the 165-kD band as et3 was 
confirmed by amino acid sequence determination.  The se- 
quence obtained matched a sequence contained in a3EpA 
in domain IIIa very near the domain I/II border (Table I). 
Therefore, band A  contains  a  disulfide-bonded  aggregate 
of u3,  132, and "y1 chains. The amounts of 165 kD plus 145 
kD (Fig. 4, lane 2) are approximately equal to that of the 
210-  or  190-kD  species,  suggesting  that  each  chain  is 
present in equimolar amounts, consistent with their assem- 
bly into  a  laminin  molecule.  Rotary-shadowed  images  of 
the  materials  in  Mono-Q  peak  1  (Fig.  5  A)  showed 
Y-shaped  molecules  consistent  with  the  molecular  shape 
expected for a  molecule containing these chains.  We sug- 
gest that this molecule (a31323,1)  be called laminin 7, and it 
will be referred to as such below. 
After disulfide  bond reduction,  electrophoretic  band B 
from Fig. 3 contained  bands  in the positions of ~/1,132,  tx3 
(165/145 kD), 1333 (140 kD), and ~/2 (105 kD). The identifi- 
cation of these chains was confirmed by Western  blotting 
(Fig. 4 B). The 210-kD band was recognized by polyclonal 
anti-laminin  1 and is in the  position  of the ~1  chain. The 
190-kD chain was recognized  by mAb C4 as ~32. The  165- 
and  145-kD bands are recognized by mAb BM-165  as the 
et3  chain.  The  140-kD  band  reacted  with  mAb  BM-140 
specific for [33. The 105-kD chain was recognized by poly- 
clonal anti-~2. The simplest interpretation  of these data is 
that  band  A  represents  a  disulfide-bonded  dimer  of one 
molecule  of  laminin  5  with  one  molecule  of laminin  7. 
The Journal of Cell Biology, Volume 132, 1996  1192 Table I. Confirmation of the Identification of the 190-kD band of Laminin 5-7 Complex as Human LAMB2 and the 145-kD a3 
Chain as LAMA3 
Rat LAMB2*  res#1641 
Human LAMB2 * 
Human laminin 132 peptide 
Mouse LAMA 1  § 
Mouse LAMA3  II 
Human LAMA3  ~ 
Human laminin ct3 peptide 
KRAGNSLAASTAEETAGSAQSRAREAE 
IIIIIIIIIIIIIIIIIIII  II  III 
KRAGNSLAASTAEETAGSAQGRAQEAE 
rllrl[ilirliiil[llJlllll 
-AGNSLAASTAEETAGSAQGRAQEA-- 
CDCSGNVDPSEA.GHCDSVTGECLKCLGNTDGAHCERCAD 
i I  1  I II  II  I  I[  I I [ 
CSCNSNGQ  LGPCDPLTGDCVNQEPK DGSPAEECDD 
I IIIIII  II  I IIIIII II]II I IIIIIIII 
CNCNSNGQ ....  LGSCHPLTGDCINQEPK  DSSPAEECDD 
I1(111111 
DSSPAEECD 
A peptide sequence obtained from the 190-kD band of the laminin 5-7 complex is located within the cDNA-predicted amino acid sequence of I]2 from rat (Hunter et al., 1989a) 
with which it has 92%, and with human (Wewer et al., 1994) with which it has 100% amino acid identity. A peptide sequence isolated from the 165-kD a3 chain of the laminin 5-7 
complex shows 100% identity to the predicted human sequence (Ryan et al., 1994) and 98% identity to mouse ct3 (Galliano et al., 1995), but shows only 33% identity to the ho- 
mologous region (domain llIa, EGF repeat 9) ofetl (Sasaki et al., 1988). 
*Hunter et al., 1989. 
*Wewer et al., 1994. 
~Sasaki et al., 1988. 
IIGalliano et al., 1995. 
IRyan et al., 1994. 
Both the  electrophoretic mobility of nonreduced B  and 
the rotary-shadowed image analysis of Mono-Q peak 1 are 
consistent with this interpretation. As shown in Fig. 5 B, in 
addition to Y-shaped molecules, the other prominent im- 
age appears  as a  molecule with two long arms and two 
short arms. Globular domains similar to the a-chain G do- 
mains are present at the ends of the long arms. The images 
suggest that laminin 5 associates with the laminin 7 mole- 
cule through its truncated short arms at the intersection of 
the long and short arms of laminin 7. 
Preliminary analyses of Mono-Q peak 2 (Fig. 2) materi- 
als  by  immunoblotting indicated  the  presence  of  both 
laminin  1  and  laminin 5  chains  but  a  reduced  relative 
amount of 132 (data not shown). Gel electrophoresis be- 
fore disulfide reduction indicated that like peak 1 materi- 
als, peak 2 laminins were present as aggregates (data not 
shown). To further characterize these materials, 131 chains 
containing laminins were isolated from amnion extracts by 
immunoaffinity chromatography using monoclonal anti- 
131 antibody 545. Three major electrophoretic species were 
detected by Coomassie blue staining (Fig. 6). Two of these 
(A and B) have electrophoretic mobilities expected to be 
multimers, and band C is predicted to be monomeric. The 
identities of bands A  and C were analyzed as detailed be- 
low. The characterization of band B is not yet complete. A 
minor band can also be seen in the same electrophoretic 
analysis with a slower mobility than band A. This band is 
in the position expected for laminin 1 and has not been 
further analyzed. 
The disulfide bond reduction product of band A  con- 
tains bands in the electrophoretic positions of 131, ~/1, a3 
(165 kD), a3 (145 kD), and 72 (Fig 6). The band in the po- 
sition of ~/1 is recognized by anti-laminin 1 antiserum (Fig. 
7, lane 2); the 131-position band is recognized by mAb 545 
(anti-131)  (Fig.  7,  lane  3);  the  presumptive  o~3-position 
bands are recognized by polyclonal anti-a3 serum (Fig. 7, 
lane 4);  the  133-position  band  is  recognized  by BM-140 
(anti-133) (Fig. 7,  lane 5); the ~2-position band is recog- 
nized by polyclonal anti-~/2 (Fig. 7, lane 6). These charac- 
teristics  are  consistent  with  an  identification of nonre- 
duced band A  as a complex of laminin 5 with laminin 6 
(a3,  131, ~/1). Therefore, laminin 5 appears to be able to 
form covalent complexes with other a3-containing lami- 
nins, although we have no evidence for a laminin 5-1ami- 
nin 5 covalent complex at this time. 
Nonreduced band C was similarly excised and reduced. 
The reduction product contains four electrophoretic spe- 
cies (Fig. 7, lane 7). The band in the position of 131 is rec- 
ognized by mAb 545 (anti-131) (Fig. 7, lane 9); the band in 
the position of ~/1 is recognized by anti-laminin 1 (Fig. 7, 
lane 9). The a3-position bands are immunoblotted by anti- 
a3 (Fig. 7, lane 10)  (the 140-kD-position band is under- 
represented due to a defect in the electrophoretic gel, but 
the portion of the band transferred is immunoblot posi- 
tive). No Coomassie blue staining is seen in the positions 
of 133 and ~/2 (Fig. 7, lane 7), nor is there reactivity with 
BM-140  (anti-133) (Fig. 7,  lane 11)  or polyclonal anti-~2 
(data not shown). These data are consistent with the iden- 
tification of unreduced band C  as monomeric laminin 6. 
The nonreduced sample does not contain monomeric lami- 
nin 7 because it was isolated by anti-131 immunoaffinity. 
The observation of 132 in the amniotic extracts was unex- 
pected since no 132 was seen in similar preparation from 
human skin or in the culture medium of human kerati- 
nocytes; therefore, the distribution of 132 was examined in 
skin and in amnion. Full-term human amnion was immuno- 
stained using antibodies specific for laminin 5  (BM-165; 
Fig. 8 A), laminin 132  (C1,  C4;  Fig. 8, B  and E, respec- 
tively), type VII collagen (NP-185;  Fig. 8 D), laminin al 
chain (mAb 1924; Fig. 8 C), and laminin 131 chain (mAb 
545; Fig. 8 F). The 132 chain is visualized only at the epithe- 
lial-stromal  interface,  equivalent  to  the  distribution  of 
type VII and laminin 5, and is not present in the capillary 
beds stained by antibodies recognizing laminin al and 131. 
Staining of human foreskin with the  same  antibodies 
showed the expected distributions for laminin 5 (Fig. 9 A), 
type VII collagen (Fig. 9 D), and laminin 1 (al chain; Fig. 
9 C; 131 chain, Fig. 9 F). Laminin 5 and collagen type VII 
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partially  purified  by  immunoaffinity  chromatography  using  a 
Sepharose column complexed with monoclonal anti-laminin 131 
antibody 545. The purification products were resolved by 3-5% 
PAGE under non-disulfide bond reducing conditions, and three 
high molecular weight bands,  A, B, and C, were visualized  by 
Coomassie blue staining.  Bands A  and C were individually ex- 
cised from the gel and the disulfide bond reduction products were 
resolved by 5% PAGE. The reduction products of band A are in 
the positions expected for 131, -yl, a3, 133, and "y2;  those of B are in 
the positions of [31, ~/1, and a3. 
Figure  5.  Peaks  A  and  B  were visualized  by EM  after  rotary 
shadowing. The images indicate that peak A  contains a mono- 
meric Y-shaped molecule with the features predicted for laminin 
7. Peak B contains more complex images. The images are consis- 
tent with what would be predicted for a covalent aggregate of 
laminins  5 and 7. Bars, 100 nm. 
dermal  junction  than  is  al  (10  C),  while  al  staining  of 
blood vessels is stronger than 131 staining. 
Discussion 
The previous description of laminin 6 indicated that the ~3 
chain,  or  a  closely  related  chain,  is  capable  of forming 
coiled-coil interactions with the 131  and ",/1 chains.  In this 
study we confirm the existence of a laminin containing au- 
thentic  a3 together with  131  and ",/1 and suggest that  this 
molecule  is  laminin  6.  Since  132 can  combine with  ul  to 
form laminin 3, it is perhaps predictable that since 131 can 
associate with o~3, 132 could also associate with ~3 to form 
laminin 7. However, as 132 is primarily associated with the 
basement membranes of blood vessels and associated with 
nerves,  it was thought that the functional specialty of 132 
collagen  show crisp,  brilliant  staining  of the  dermal-epi- 
dermal junction.  Anti-a/antibody staining is very strong 
for the  dermal  vasculature,  but  relatively  less  intense  at 
the  dermal-epidermal  junction.  Anti-131  antibodies  stain 
the  dermal-epidermal  junction  more  intensely  and  also 
recognize the dermal vasculature, consistent with the pos- 
sibility of 131 being present in laminin 1 and laminin 6. 132 
staining (C1 and C4; Fig. 9, B and E, respectively) was ob- 
served  around  nerves,  but  was  absent  or  only  weakly 
present  at the dermal-epidermal junction.  This is in con- 
trast to what is seen in bovine skin (Fig. 10). In this case, 
132 (C1  and C4; Fig. 10, B  and E, respectively) is distrib- 
uted around nerves and at the dermal--epidermal junction 
of both adult (10 B) and fetal (10 E) bovine skin. As in hu- 
man skin, 131 staining (10 F) is stronger at the dermal-epi- 
Figure 7.  Nonreduced bands A and C (Fig. 6) were further char- 
acterized after excision  from the gel,  disulfide  bond reduction, 
resolution of the reduction products on a 5%  SDS-PAGE gel, 
transfer to nitrocellulose, and Western analysis using: lanes I and 
7, Coomassie blue; lanes 2 and 8, polyclonal anti-laminin 1 anti- 
serum (Sigma Chemical Co.); lanes 3 and 9, mAb 545 (anti-131); 
lanes 4 and 10, polyclonal anti-et3 serum; lanes 5 and ll, mAb 
BM-140 (anti-133); and lane 6, polyclonal anti-~/2. The results indi- 
cate that band B  contains monomeric laminin 6 (oc3131~/1), and 
band A contains a mixture of laminins 5 and 6. 
The Journal of Cell Biology,  Volume 132, 1996  1194 Figure  8.  Cryosections  of full-term human  amnion  were  pro- 
cessed for indirect  immunofluorescence  using: (A) mAb BM-165 
specific for ct3; (B) mAb C1 specific for 132; (C) mAb 1924 spe- 
cific for otl; (D) mAb NP-185 specific for type VII collagen; (E) 
mAb C4 specific for 132; and (F) mAb 545 specific for 131. 
was related to those tissues. The aberrant neuromuscular 
junctions  in  132-deficient  mice (Noakes et al.,  1995a)  are 
consistent with that expectation. Therefore, the role of 132 
in amnion is unclear. 
The 131 chain has been shown to mediate laminin poly- 
merization in vitro through interactions of the VI domain 
(Yurchenco  et  al.,  1985;  Paulsson,  1988;  Schittney  and 
Yurchenco,  1990).  The  rat  132-chain  VI  domain  shares 
70%  sequence  identity  with  the  human  131  VI  domain, 
strongly suggesting that 132 participates in laminin 3 poly- 
merization.  131  has  also  been  implicated  in  cell  binding 
through the sequences PDSGR and YIGSR in the ninth 
EGF repeat of domain III (Graf et al., 1987; Kleinman et 
al., 1989). These sequences are not found in 132, yet the cell 
attachment  activity of 131  and  132--containing  laminins  2 
and 4 are indistinguishable (Brown et al., 1994). Two activ- 
ities have been reported to be specific to the 132 chain: ad- 
hesion of ciliary ganglion neurons to the sequence LRE in 
132 (Hunter et al.,  1989b),  and the in vitro binding of 132 
(probably laminin 4) containing placental laminin to BM- 
90 (Brown et al.,  1994).  The physiological significance of 
these  observations is not  known.  In view of this current 
state of understanding of the laminin 3 and 4 function, it is 
not possible to predict any functional differences between 
laminin 6 and laminin 7. 
The complex of laminins 6  or 7 with laminin 5 is most 
likely to derive from an interaction of the 133-chain VI do- 
main with the ct3-chain short arm domain III in laminin 7. 
This prediction  reflects our interpretation  of the  rotary- 
shadowed image of the complex as the short arm of lami- 
nin 5 interacting with a laminin 6/7 domain near the inter- 
section of the laminin 6/7 short arms. Support for a role of 
the  133-chain VI domain comes from the  presence of an 
unpaired cysteinyl residue in that domain (Gerecke et al., 
1994) and the absence of any other globular domain at the 
NH2 terminus of the  fully processed laminin 5  molecule 
(Marinkovich et al., 1992b). This unpaired cysteine is con- 
served between human (Gerecke et al., 1994)  and mouse 
(Sasaki et al., 1988). The contributor of the other unpaired 
cysteine from laminin 7  is not known, but since complex 
Figure  9.  Cryosection  of human 
foreskin  processed  for immuno- 
fluorescence  using: (A)  mAb 
BM-165  specific  for  ct3; (B) 
mAb  C1  specific  for  132; (C) 
mAb 1924 specific for ctl;  (D) 
mAb  NP-185 specific  for  type 
VII collagen;  (E) mAb C4 spe- 
cific for  132; and  (F)  mAb 545 
specific for 131. SC, stratum cor- 
neum;  BMZ,  basement  mem- 
brane zone. 
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skin (A-C) and fetal bovine skin (D-F) 
processed  for  immunofluorescence  us- 
ing: (A, D) polyclonal antibody against 
human laminin 1; (B, E) polyclonal anti- 
body against laminin 5; and (C, F) mAb 
C4 specific for [~2. 
formation between laminin 5 and other laminins has only 
been seen between truncated a-chain-containing laminins 
(i.e., laminin 6 and laminin 7), despite the fact that other 
laminins  are  synthesized  by  keratinocytes  and  present 
within the basement membranes of skin and amnion, the 
most likely bonding partner within laminin 7 for the [~3 VI 
domain is the or3 chain. The exact location of the required 
a3 cysteinyl residue is not known; however, the final EGF 
repeat in domain Ilia of both e~3 (Ryan et al., 1994) and e~4 
(Iivanainen et al.,  1995)  is only a half repeat. As it is un- 
clear if the half EGF repeat is capable of correctly folding 
to form any of the typical disulfide bridges, any of the con- 
tained  cysteine residues  could remain unpaired.  One  of 
the presumptive unpaired  cysteine residues is  contained 
within the determined peptide sequence from the 145-kD 
a3,  so this  cysteinyl residue  is  retained even within  the 
most fully processed form of a3.  We have thus far been 
unable to confirm the identification of the 165-kD or3 as 
a3EpA; as we have not identified protein sequences specific 
to either splice variant, there is a formal possibility that the 
165-kD a3 derives from a3EpB. However, several lines of 
evidence argue against this possibility. The 200-kD precur- 
sor  of the  165-kD  chain  is  the  only a3  chain  detected 
within cultured epithelial cells (Marinkovich et al., 1992b). 
The 200- and 165-kD (and very minor amounts of 145 kD) 
forms are the only a3 species found in the culture medium 
of normal human keratinocytes and of SCC-25 cells (a line 
derived from a  squamous cell carcinoma). The 165-  and 
145-kD c~3 forms are only found extracellularly and ap- 
pear  sequentially in  pulse-chase  experiments  (Marinko- 
vich et al., 1992b) in both keratinocyte and WISH cell cul- 
tures,  a3EpB  is  only  a  minor  transcription  product  of 
keratinocytes (Kallunki et al., 1992; Galliano et al., 1995), 
and there is no evidence that e~3EpB is translated by kerati- 
nocytes. The 200-kD intracellular precursor corresponds 
well with the calculated mass of 184 kD plus an additional 
mass of ~20 kD due to glycosylation (Champliaud, M.-F., 
unpublished observations) for a3Ep  A. No protein product 
of the size predicted to correspond to a3Ep  B has been de- 
tected in these studies despite the fact that the a3 antibod- 
ies used here for immunoisolation recognize epitopes pre- 
dicted to exist in all or3 splice variants. 
It is not entirely clear where 200-kD a3  is  cleaved to 
produce the  165-  and  145-kD  forms. However, since  at 
least the domain III-II junction is present within a3  145 
kD, the calculated mass of et3 is insufficient to include the 
entire  G  domain  sequence.  Instead,  assuming  that  do- 
mains I and II are not cleaved, repeats 4 and 5 of domain 
G cannot be be present in the 145-kD form. Furthermore, 
the mass difference between the 200 kD and 165 kD is too 
large to be only domain IIIa. Therefore, the most likely 
consequence of the a3 processing is an initial loss of G re- 
peats 4 and 5 during the 200-265-kD conversion and loss 
of NH2-terminal domain IIIa during the conversion from 
165  to  154  kD.  The  observed mass  changes correspond 
quite well to masses calculated from the predicted amino 
acid sequence, assuming an average addition of 10% due 
to glycosylation. A similar proteolytic processing between 
G repeats 3 and 4 has been observed for a2 (Wewer et al., 
1994). 
The severe truncation of the laminin 5 short arms, espe- 
cially after processing, deprives the molecule of the  do- 
mains believed to be necessary for self-polymerization. In 
addition, the ~/2 chain does not bind nidogen, and there- 
fore cannot interact with type IV collagen, perlecan, or the 
fibulins (Brown et al.,  1995;  Mayer et al.,  1995). This is 
consistent with the model (Fig.  11) that laminin 5  alone 
cannot generate epithelial-stromal stability. The model as- 
sumes that ot6134 in the hemidesmosome binds the or3 G 
domain. This derives from published studies showing that 
et6[34 binds laminin 5 (Sonnenberg et al., 1993; Niessen et 
al., 1994) and that the antibody BM-165 that can deepithe- 
lize fragments of human skin in vitro, as well as inhibit cell 
attachment of epithelial cells in vitro, specifically immuno- 
The Jourrlal of Cell Biology, Volume 132, 1996  1196 Figure 11.  Model of the proposed function  of the laminin  5-7 
complex in epidermal-stromal adhesion.  The laminin  5-7 com- 
plex is shown mediating the interactions  of the epithelial  trans- 
membrane hemidesmosomal protein ~6134 through the G domain 
of ct3 to polymerized laminin, through the VI domains of laminin 
6  or 7,  and with  the  type IV collagen  network and  perlecan, 
through nidogen binding to the ~tl chain of laminin 6 or 7. 
blots  the  et3  chain.  The  epitope recognized by this  anti- 
body resides in the first repeat of the G domain (Champli- 
aud, M.-F., unpublished results). Assuming the G  domain 
of or3 is the primary site of cell binding, the NH2 terminus 
of the laminin 5 molecule must strongly interact with an- 
other species to bind components of the basement mem- 
brane. The observed covalent associations with laminin 6 
and laminin 7 fill this requirement. The "yl chains of lami- 
nins 6 and 7 provide the binding site for nidogen. The VI 
domains of [31, [32, and ~1 provide potential sites for poly- 
merization.  Thus,  in  combination  with  laminins  6  and  7, 
laminin 5 is able to mediate binding of the epithelial cell to 
the  basement  membrane.  However,  complex  formation 
with laminins 6  and 7  need  not provide the  only mecha- 
nism.  The  anchoring  fibrils  secure  the  basement  mem- 
brane to the stroma through interactions of the NC-1 do- 
main  of  type  VII  collagen.  It  is  likely  that  type  VII 
collagen  interacts  directly with  monomeric laminin  5  or 
with the laminin 5-6 or laminin 5-7 complexes, but this has 
not yet been reported. 
Since the basement membranes of both the dermal-epi- 
dermal junction  and the amniotic epithelium contain the 
structures and proteins characteristic of the contained an- 
choring complexes, it is surprising that the amnion, but not 
skin, is rich in 132-containing laminins. Even more perplex- 
ing is the presence of 132-containing laminins in both fetal 
and adult calf skin. We have observed only one ultrastruc- 
tural correlate with these differences, that being that the 
basolateral  plasma  membranes  and  adjacent  basement 
membrane zone of the fetal calf and  the  human amnion 
are highly fenestrated relative to human skin, with many 
of the  anchoring fibrils appearing to stabilize the  infold- 
ings by spanning the matrix between the folds. Consistent 
with the possibility that 132-containing laminins determine 
or stabilize basement membrane infolding is the observa- 
tion that 132-/_ mice show significantly reduced junctional 
folds within  the  neuromuscular junctions  (Noakes et al., 
1995a). Recently, a defect in the visceral epithelial cells of 
the  [32-deficient  mouse  glomerulus  has  been  described 
(Noakes et al., 1995b). The foot processes of these cells are 
frequently fused. This is again consistent with the possibil- 
ity that 132-containing laminins generate or stabilize fenes- 
trated  cellular  structures.  However, it  is  not  at  all  clear 
how a laminin repertoire could influence this architecture. 
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